The interrelationship between hepatitis C virus and HLA. (Q42993371)

12 November 2017

The interrelationship between hepatitis C virus and HLA. (English)

1 reference

12 November 2017

1 reference

Donaldson PT

1

1 reference

12 November 2017

1 April 1999

1 reference

European Journal of Clinical Investigation

12 November 2017

1 reference

12 November 2017

29

1 reference

12 November 2017

4

1 reference

12 November 2017

280-283

1 reference

Increased frequency of the HLA-DR15 (B1*15011) allele in German patients with self-limited hepatitis C virus infection.

12 November 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00465.X

HLA and disease associations: detecting the strongest association

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00465.X

Hepatitis C virus six years on.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00465.X

The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00465.X

Clinical outcomes after transfusion-associated hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00465.X

HLA-DR5 antigen. A genetic factor influencing the outcome of hepatitis C virus infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00465.X

HLA class II genes in chronic hepatitis C virus-infection and associated immunological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00465.X

Influence of HLA haplotypes on the clinical courses of individuals infected with hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00465.X

Immunological studies before and during interferon therapy in chronic HBV infection: identification of factors predicting response

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00465.X

Absence of association between HLA antigens and chronicity of viral hepatitis in haemodialyzed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00465.X

Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00465.X

Association between HLA class II alleles and protection from or susceptibility to chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00465.X

MHC class II genes influence the susceptibility to chronic active hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00465.X

Immunologic features and HLA associations in chronic viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00465.X

Are HLA class II and immunoglobulin constant region genes involved in the pathogenesis of mixed cryoglobulinemia type II after hepatitis C virus infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00465.X

10.1046/J.1365-2362.1999.00465.X

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference

PubMed ID

10231339